2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries

Booking.com

2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has established a commercial agreement with one of the largest private cancer hospitals in the Nordic countries to evaluate IndiTreat’s usefulness in clinical practise.
2cureX launches the IndiTreat® test in the European market in 2020. In preparation, 2cureX plans to establish commercial agreements with four innovative cancer centers in selected European markets by the end of 2019. For 2cureX, such collaborations are valuable opportunities to gain experience with the IndiTreat® test in daily clinical practice.

Source: 2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries

Booking.com
Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.